Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

Treating pulmonary hypertension in the elderly.

Campean IA, Lang IM.

Expert Opin Pharmacother. 2020 Mar 31:1-7. doi: 10.1080/14656566.2020.1739270. [Epub ahead of print]

PMID:
32228234
2.

Diastolic Pulmonary Artery to Pulmonary Capillary Wedge Pressure Difference: A Predictor of Outcome After Left Ventricular Assist Device Implantation.

Lang IM.

J Am Heart Assoc. 2020 Apr 7;9(7):e016110. doi: 10.1161/JAHA.120.016110. Epub 2020 Mar 30. No abstract available.

3.

Impact of treatment strategies on long-term outcome of CTO patients.

Roth C, Goliasch G, Aschauer S, Gangl C, Ayoub M, Distelmaier K, Frey B, Lang IM, Berger R, Mashayekhi K, Ferenc M, Hengstenberg C, Toma A.

Eur J Intern Med. 2020 Mar 14. pii: S0953-6205(20)30096-0. doi: 10.1016/j.ejim.2020.03.008. [Epub ahead of print]

PMID:
32184031
4.

Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes.

Wadowski PP, Weikert C, Pultar J, Lee S, Eichelberger B, Koppensteiner R, Lang IM, Panzer S, Gremmel T.

Cardiovasc Drugs Ther. 2020 Feb;34(1):53-63. doi: 10.1007/s10557-019-06932-7.

5.

Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study.

Sitbon O, Chin KM, Channick RN, Benza RL, Di Scala L, Gaine S, Ghofrani HA, Lang IM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Tapson VF, Galiè N, Hoeper MM.

J Heart Lung Transplant. 2020 Apr;39(4):300-309. doi: 10.1016/j.healun.2019.12.013. Epub 2020 Jan 21.

6.

Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment.

Gerges C, Gerges M, Friewald R, Fesler P, Dorfmüller P, Sharma S, Karlocai K, Skoro-Sajer N, Jakowitsch J, Moser B, Taghavi S, Klepetko W, Lang IM.

Circulation. 2020 Feb 4;141(5):376-386. doi: 10.1161/CIRCULATIONAHA.119.041515. Epub 2020 Jan 3.

PMID:
31896275
7.

The burden of comorbidities in pulmonary arterial hypertension.

Lang IM, Palazzini M.

Eur Heart J Suppl. 2019 Dec;21(Suppl K):K21-K28. doi: 10.1093/eurheartj/suz205. Epub 2019 Dec 17.

8.

The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension.

Badagliacca R, Papa S, Matsubara H, Lang IM, Poscia R, Manzi G, Vizza CD.

Int J Cardiol. 2020 Feb 15;301:183-189. doi: 10.1016/j.ijcard.2019.10.043. Epub 2019 Nov 13.

PMID:
31806280
9.

Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway Agents.

McLaughlin VV, Channick R, De Marco T, Farber HW, Gaine S, Galié N, Krasuski RA, Preston I, Souza R, Coghlan JG, Frantz RP, Hemnes A, Kim NH, Lang IM, Langleben D, Li M, Sitbon O, Tapson V, Frost A.

Chest. 2020 Apr;157(4):955-965. doi: 10.1016/j.chest.2019.10.043. Epub 2019 Nov 16. Review.

10.

Neutrophil extracellular traps and monocyte subsets at the culprit lesion site of myocardial infarction patients.

Mangold A, Hofbauer TM, Ondracek AS, Artner T, Scherz T, Speidl WS, Krychtiuk KA, Sadushi-Kolici R, Jakowitsch J, Lang IM.

Sci Rep. 2019 Nov 8;9(1):16304. doi: 10.1038/s41598-019-52671-y.

11.

Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?

Lang IM, Matsubara H.

Eur Respir J. 2019 Oct 24;54(4). pii: 1901639. doi: 10.1183/13993003.01639-2019. Print 2019 Oct. No abstract available.

PMID:
31649148
12.

Pulmonary artery denervation - the time has come for a multicentre blinded randomised controlled trial.

Lang IM.

EuroIntervention. 2019 Oct 20;15(8):659-661. doi: 10.4244/EIJV15I8A122. No abstract available.

13.

What is new in the 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy?

Lang IM.

Wien Klin Wochenschr. 2020 Feb;132(3-4):69-72. doi: 10.1007/s00508-019-1529-y. Epub 2019 Sep 23. Review.

14.

Treprostinil for the treatment of chronic thromboembolic pulmonary hypertension.

Sadushi-Kolici R, Lang IM.

Expert Rev Respir Med. 2019 Sep 23:1-7. doi: 10.1080/17476348.2019.1652094. [Epub ahead of print]

PMID:
31545126
15.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group.

Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405. No abstract available.

PMID:
31504429
16.

Sex-specific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH registry.

Barco S, Klok FA, Konstantinides SV, Dartevelle P, Fadel E, Jenkins D, Kim NH, Madani M, Matsubara H, Mayer E, Pepke-Zaba J, Simonneau G, Delcroix M, Lang IM.

J Thromb Haemost. 2020 Jan;18(1):151-161. doi: 10.1111/jth.14629. Epub 2019 Sep 24.

PMID:
31479557
17.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Áinle FN, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).

Eur Respir J. 2019 Oct 9;54(3). pii: 1901647. doi: 10.1183/13993003.01647-2019. Print 2019 Sep. No abstract available.

PMID:
31473594
18.

Neutrophil extracellular traps and fibrocytes in ST-segment elevation myocardial infarction.

Hofbauer TM, Mangold A, Scherz T, Seidl V, Panzenböck A, Ondracek AS, Müller J, Schneider M, Binder T, Hell L, Lang IM.

Basic Res Cardiol. 2019 Jul 16;114(5):33. doi: 10.1007/s00395-019-0740-3.

19.

Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors.

Wadowski PP, Pultar J, Weikert C, Eichelberger B, Panzer B, Huber K, Lang IM, Koppensteiner R, Panzer S, Gremmel T.

Res Pract Thromb Haemost. 2019 May 22;3(3):383-390. doi: 10.1002/rth2.12213. eCollection 2019 Jul.

20.

[Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension].

Rosenkranz S, Diller GP, Dumitrescu D, Ewert R, Ghofrani HA, Grünig E, Halank M, Held M, Kaemmerer H, Klose H, Kovacs G, Konstantinides S, Lang IM, Lange TJ, Leuchte H, Mayer E, Olschewski A, Olschewski H, Olsson KM, Opitz C, Schermuly RT, Seeger W, Wilkens H, Hoeper MM.

Dtsch Med Wochenschr. 2019 Sep;144(19):1367-1372. doi: 10.1055/a-0918-3772. Epub 2019 Jul 5. German.

21.

Characterization and mechanism of the esophago-esophageal contractile reflex of the striated muscle esophagus.

Lang IM, Medda BK, Shaker R.

Am J Physiol Gastrointest Liver Physiol. 2019 Sep 1;317(3):G304-G313. doi: 10.1152/ajpgi.00138.2019. Epub 2019 Jul 3.

PMID:
31268772
22.

Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?

Lang IM, Matsubara H.

Eur Respir J. 2019 May 23;53(5). pii: 1900843. doi: 10.1183/13993003.00843-2019. Print 2019 May. No abstract available. Erratum in: Eur Respir J. 2019 Oct 24;54(4):.

PMID:
31123025
23.

Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer.

Grilz E, Marosi C, Königsbrügge O, Riedl J, Posch F, Lamm W, Lang IM, Pabinger I, Ay C.

J Thromb Haemost. 2019 Aug;17(8):1335-1344. doi: 10.1111/jth.14484. Epub 2019 Jun 17.

24.

Chronic thromboembolic pulmonary hypertension in Austria and Japan.

Chausheva S, Naito A, Ogawa A, Seidl V, Winter MP, Sharma S, Sadushi-Kolici R, Campean IA, Taghavi S, Moser B, Klepetko W, Ishida K, Matsubara H, Sakao S, Lang IM.

J Thorac Cardiovasc Surg. 2019 Aug;158(2):604-614.e2. doi: 10.1016/j.jtcvs.2019.01.019. Epub 2019 Jan 21.

PMID:
31084984
25.

Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.

Chin KM, Rubin LJ, Channick R, Di Scala L, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Simonneau G, Sitbon O, Tapson VF.

Circulation. 2019 May 21;139(21):2440-2450. doi: 10.1161/CIRCULATIONAHA.118.039360.

26.

Functional capillary impairment in patients with ventricular assist devices.

Wadowski PP, Steinlechner B, Zimpfer D, Schlöglhofer T, Schima H, Hülsmann M, Lang IM, Gremmel T, Koppensteiner R, Zehetmayer S, Weikert C, Pultar J, Jilma B.

Sci Rep. 2019 Apr 11;9(1):5909. doi: 10.1038/s41598-019-42334-3.

27.

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA.

Kardiol Pol. 2019;77(3):245-326. doi: 10.5603/KP.2019.0049. No abstract available.

28.

Platelet reactivity patterns in patients treated with dual antiplatelet therapy.

Winter MP, Schneeweiss T, Cremer R, Biesinger B, Hengstenberg C, Prüller F, Wallner M, Kolesnik E, von Lewinski D, Lang IM, Siller-Matula JM.

Eur J Clin Invest. 2019 Mar 18:e13102. doi: 10.1111/eci.13102. [Epub ahead of print]

29.

Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.

Gerges C, Gerges M, Lang IM.

Eur Respir J. 2019 Mar 7;53(3). pii: 1802393. doi: 10.1183/13993003.02393-2018. Print 2019 Mar. No abstract available.

PMID:
30846449
30.

Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension.

Räber L, Ueki Y, Lang IM.

EuroIntervention. 2019 Oct 4;15(9):e814-e815. doi: 10.4244/EIJ-D-18-01212. No abstract available.

31.

Discriminatory power of scoring systems for outcome prediction in patients with extracorporeal membrane oxygenation following cardiovascular surgery†.

Schrutka L, Rohmann F, Binder C, Haberl T, Dreyfuss B, Heinz G, Lang IM, Felli A, Steinlechner B, Niessner A, Laufer G, Goliasch G, Wiedemann D, Distelmaier K.

Eur J Cardiothorac Surg. 2019 Sep 1;56(3):534-540. doi: 10.1093/ejcts/ezz040.

PMID:
30789227
32.

Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies.

Renda G, Patti G, Lang IM, Siller-Matula JM, Hylek EM, Ambrosio G, Haas S, De Caterina R; Working Group on Thrombosis of the Italian Society of Cardiology.

Int J Cardiol. 2019 Jul 1;286:198-207. doi: 10.1016/j.ijcard.2019.02.004. Epub 2019 Feb 8. Review.

PMID:
30777407
33.

Diffusion capacity of the lung-a disease biomarker linking ventilation and circulation.

Shafran I, Lang IM.

J Heart Lung Transplant. 2019 Feb;38(2):130-132. doi: 10.1016/j.healun.2018.11.008. Epub 2018 Dec 1. No abstract available.

PMID:
30691594
34.

Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study.

Beghetti M, Channick RN, Chin KM, Di Scala L, Gaine S, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Galiè N.

Eur J Heart Fail. 2019 Mar;21(3):352-359. doi: 10.1002/ejhf.1375. Epub 2019 Jan 11.

35.

Endothelial cells from pulmonary endarterectomy specimens possess a high angiogenic potential and express high levels of hepatocyte growth factor.

Naito A, Sakao S, Lang IM, Voelkel NF, Jujo T, Ishida K, Sugiura T, Matsumiya G, Yoshino I, Tanabe N, Tatsumi K.

BMC Pulm Med. 2018 Dec 29;18(1):197. doi: 10.1186/s12890-018-0769-3.

36.

Intermittent Hypoxia Activates Duration-Dependent Protective and Injurious Mechanisms in Mouse Lung Endothelial Cells.

Wohlrab P, Soto-Gonzales L, Benesch T, Winter MP, Lang IM, Markstaller K, Tretter V, Klein KU.

Front Physiol. 2018 Dec 6;9:1754. doi: 10.3389/fphys.2018.01754. eCollection 2018.

37.

Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial.

Barco S, Russo M, Vicaut E, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Danays T, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Klok FA, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G, Konstantinides SV.

Clin Res Cardiol. 2019 Jul;108(7):772-778. doi: 10.1007/s00392-018-1405-1. Epub 2018 Dec 18.

38.

Pharyngoesophageal and cardiorespiratory interactions: potential implications for premature infants at risk of clinically significant cardiorespiratory events.

Hasenstab KA, Nawaz S, Lang IM, Shaker R, Jadcherla SR.

Am J Physiol Gastrointest Liver Physiol. 2019 Feb 1;316(2):G304-G312. doi: 10.1152/ajpgi.00303.2018. Epub 2018 Dec 13.

39.

Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018.

Rosenkranz S, Lang IM, Blindt R, Bonderman D, Bruch L, Diller GP, Felgendreher R, Gerges C, Hohenforst-Schmidt W, Holt S, Jung C, Kindermann I, Kramer T, Kübler WM, Mitrovic V, Riedel A, Rieth A, Schmeisser A, Wachter R, Weil J, Opitz CF.

Int J Cardiol. 2018 Dec 1;272S:53-62. doi: 10.1016/j.ijcard.2018.08.080. Epub 2018 Aug 27. Review.

PMID:
30527996
40.

Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial.

Sadushi-Kolici R, Jansa P, Kopec G, Torbicki A, Skoro-Sajer N, Campean IA, Halank M, Simkova I, Karlocai K, Steringer-Mascherbauer R, Samarzija M, Salobir B, Klepetko W, Lindner J, Lang IM.

Lancet Respir Med. 2019 Mar;7(3):239-248. doi: 10.1016/S2213-2600(18)30367-9. Epub 2018 Nov 23.

PMID:
30477763
41.

Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry.

Klok FA, Barco S, Konstantinides SV, Dartevelle P, Fadel E, Jenkins D, Kim NH, Madani M, Matsubara H, Mayer E, Pepke-Zaba J, Delcroix M, Lang IM.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801687. doi: 10.1183/13993003.01687-2018. Print 2018 Dec. No abstract available.

PMID:
30409820
42.

Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia: A Case Report.

Skride A, Sablinskis M, Sablinskis K, Lejniece S, Lejnieks A, Klepetko W, Lang IM.

Am J Case Rep. 2018 Oct 19;19:1245-1248. doi: 10.12659/AJCR.909778.

43.

Effects of esophageal acidification on esophageal reflexes controlling the upper esophageal sphincter.

Lang IM, Medda BK, Shaker R.

Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G45-G54. doi: 10.1152/ajpgi.00292.2018. Epub 2018 Oct 11.

44.

Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer.

Grilz E, Posch F, Königsbrügge O, Schwarzinger I, Lang IM, Marosi C, Pabinger I, Ay C.

Thromb Haemost. 2018 Nov;118(11):1875-1884. doi: 10.1055/s-0038-1673401. Epub 2018 Oct 8.

PMID:
30296815
45.

Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018.

Wilkens H, Konstantinides S, Lang IM, Bunck AC, Gerges M, Gerhardt F, Grgic A, Grohé C, Guth S, Held M, Hinrichs JB, Hoeper MM, Klepetko W, Kramm T, Krüger U, Lankeit M, Meyer BC, Olsson KM, Schäfers HJ, Schmidt M, Seyfarth HJ, Ulrich S, Wiedenroth CB, Mayer E.

Int J Cardiol. 2018 Dec 1;272S:69-78. doi: 10.1016/j.ijcard.2018.08.079. Epub 2018 Aug 28. Review.

PMID:
30195840
46.

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. No abstract available.

PMID:
30165544
47.

9-year clinical follow-up of patients with ST-segment elevation myocardial infarction with Genous or TAXUS Liberté stents.

Giurgea GA, Heuberger A, Babayev J, Winkler S, Schlager O, Lang IM, Gyöngyösi M.

PLoS One. 2018 Aug 6;13(8):e0201416. doi: 10.1371/journal.pone.0201416. eCollection 2018.

48.

Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP).

Etscheid M, Subramaniam S, Lochnit G, Zabczyk M, Undas A, Lang IM, Hanschmann KM, Kanse SM.

Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3397-3406. doi: 10.1016/j.bbadis.2018.07.030. Epub 2018 Aug 1.

49.

Lipid profile and long-term outcome in premature myocardial infarction.

Winter MP, Wiesbauer F, Blessberger H, Pavo N, Sulzgruber P, Huber K, Wojta J, Distelmaier K, Lang IM, Goliasch G.

Eur J Clin Invest. 2018 Oct;48(10):e13008. doi: 10.1111/eci.13008. Epub 2018 Aug 13.

PMID:
30062727
50.

Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure.

Wurm R, Schrutka L, Hammer A, Moertl D, Berger R, Pavo N, Lang IM, Goliasch G, Huelsmann M, Distelmaier K.

Eur J Clin Invest. 2018 Sep;48(9):e12998. doi: 10.1111/eci.12998. Epub 2018 Aug 1.

Supplemental Content

Support Center